Nicotine inhaler substantially improves smoking cessation treatment Many smokers will tell you that giving up cigarettes is not easy. That said, a recent study published in Nicotine & Tobacco Research ...

Qnovia, Inc., a pharmaceutical and medtech company revolutionizing inhaled therapeutics, today announced positive results from its Phase 1 clinical trial evaluating the safety and efficacy of RespiRx™ ...

A British inventor has come up with a so-called "safe" cigarette: It's a nicotine inhaler shaped like a cigarette that delivers doses of the addictive chemical equal to those of cigarettes. Unlike the ...

Saying that you're going to quit smoking is easy. What's harder is not lighting up over the long term and, ideally, forever. That's why smokers struggle with quitting. It takes an average of five to ...

Qnovia Inc., a Richmond startup focused on smoking-cessation technology, has received investigational new drug clearance from the Food and Drug Administration for its nicotine inhaler product — a key ...

Smokers trying to kick the habit are getting a new source of help: The Food and Drug Administration approved the first smokeless nicotine inhaler Monday. The Nicotrol Inhaler, to be sold by ...

LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a novel alternative in ...

RICHMOND, Va., Jan. 7, 2025 /PRNewswire/ -- Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery ...